Risk-Adapted Therapy for Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: Analysis From a Multicenter Study: Abstract and Introduction

Abstract and Introduction: For patients with early-stage nasal-type extranodal NK/T-cell lymphoma, the most effective treatment was risk-adapted therapy of radiotherapy alone for the low-risk group and radiotherapy consolidated by chemotherapy for the high-risk group.